Summary
Percutaneous closure of patent foramen ovale does not reduce the risk of recurrent stroke or transient ischemic attack of unknown origin compared with standard medical therapy alone, according to new findings from the CLOSURE I trial.
- Interventional Techniques & Devices Clinical Trials
- Cerebrovascular Disease
- Interventional Techniques & Devices
- Episodic & Paroxysmal Disorders
- © 2010 MD Conference Express
Tools
CLOSURE I: No Reduction in Recurrent Stroke or TIA with Septal Closure
Permalink:
Table of contents
Cited By...
- No citing articles found.